Table 1 Participant demographics

From: Functional magnetic resonance spectroscopy of glutamate in schizophrenia and major depressive disorder: anterior cingulate activity during a color-word Stroop task

Group

Controls

MDD

SZ

P

n

16

16

16

 

Age

23.9±4.7

21.7±3.3

22.7±2.9

0.234

M/F

11/5

6/10

13/3

0.030

R/L

14/2

14/2

15/1

0.810

Educ

3.1±0.9

2.6±0.6

2.2±0.8

0.010

PEduc

3.1±0.9

3.0±0.6

3.3±0.8

0.659

HAM-A

 

12.7±10.9

  

HAM-D

 

12.4±9.1

  

Mania

 

5.4±6.8

  

Montg

 

17.4±10.4

  

CPZ (mg)

  

358±307

 

SANS

  

9.7±7.7

 

SAPS

  

7.6±10.4

 

Illness Duration (months)

 

28.6±14.4

29.5±15.7

 
  1. Abbreviations: CPZ, chlorpromazine equivalent; Educ, education rating of the participant (1- gr. 10 or lower, 2- completed high school, 3- 1–3 years of college/university, 4- 43 years of college/university); HAM-A, Hamilton Anxiety Scale; HAM-D, Hamilton Depression Scale; M/F, male/female; Mania, mania rating from the Young Mania Rating Scale; Montg, result of the Montgomery Asperg Depression Scale; SANS, Scale for Assessment of Negative Symptoms; PEduc, education rating of the participant’s parent (1- gr.10 or lower, 2-completed high school, 3- 1–3 years of college/university, 4- 43 years of college/university); R/L, right/left; SAPS, Scale for Assessment of Positive Symptoms.
  2. P – ANOVA test for significance (alpha=0.05, two-tailed), bolded values indicate significance.
Back to article page